The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-[4-chloro-3-(trifluoromethyl)phenyl]-3-[4-[4-(1-methylpyrazol-4-yl)-1-oxo-phthalazin-2-yl]phenyl]urea ID: ALA4785054
PubChem CID: 162666686
Max Phase: Preclinical
Molecular Formula: C26H18ClF3N6O2
Molecular Weight: 538.92
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cn1cc(-c2nn(-c3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cc3)c(=O)c3ccccc23)cn1
Standard InChI: InChI=1S/C26H18ClF3N6O2/c1-35-14-15(13-31-35)23-19-4-2-3-5-20(19)24(37)36(34-23)18-9-6-16(7-10-18)32-25(38)33-17-8-11-22(27)21(12-17)26(28,29)30/h2-14H,1H3,(H2,32,33,38)
Standard InChI Key: YQINYKCKYYUISL-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 42 0 0 0 0 0 0 0 0999 V2000
1.9797 -5.3571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9785 -6.1766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6866 -6.5856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6848 -4.9482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3934 -5.3535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3968 -6.1787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1091 -6.5861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8227 -6.1728 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8193 -5.3477 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1024 -4.9357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1114 -7.4033 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5315 -6.5795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5300 -7.3971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2379 -7.8037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9455 -7.3931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9407 -6.5717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2321 -6.1688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6549 -7.7988 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3609 -7.3873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0703 -7.7931 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3576 -6.5702 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0979 -4.1185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7570 -3.6347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5002 -2.8589 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6830 -2.8634 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4349 -3.6420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9769 -2.1951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7763 -7.3816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4839 -7.7883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1895 -7.3775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1866 -6.5594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4723 -6.1539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7697 -6.5670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8921 -6.1470 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
11.8987 -7.7836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9016 -8.6007 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.6049 -7.3724 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.6004 -8.1884 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
7 11 2 0
8 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
15 18 1 0
18 19 1 0
19 20 1 0
19 21 2 0
10 22 1 0
22 23 2 0
23 24 1 0
24 25 1 0
25 26 2 0
26 22 1 0
24 27 1 0
20 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 28 1 0
31 34 1 0
30 35 1 0
35 36 1 0
35 37 1 0
35 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 538.92Molecular Weight (Monoisotopic): 538.1132AlogP: 6.10#Rotatable Bonds: 4Polar Surface Area: 93.84Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.39CX Basic pKa: 1.56CX LogP: 5.67CX LogD: 5.67Aromatic Rings: 5Heavy Atoms: 38QED Weighted: 0.29Np Likeness Score: -2.03
References 1. Zhang XJ,Xu Y,Mou HX,Wang S,Hao SY,Chen SW. (2020) The synthesis and anti-tumour properties of novel 4-substituted phthalazinones as Aurora B kinase inhibitors., 30 (23.0): [PMID:32941989 ] [10.1016/j.bmcl.2020.127556 ]